[18F]AlF-NOTA-FAPI-04 PET/CT for Predicting Pathologic Response of Resectable Esophageal Squamous Cell Carcinoma to Neoadjuvant Camrelizumab and Chemotherapy: A Phase II Clinical Trial.
| Autor: | Dong, Yinjun, Wang, Zhendan, Hu, Xinying, Sun, Yuhong, Qin, Jingjie, Qin, Qiming, Liu, Shuguang, Yuan, Shuanghu, Yu, Jinming, Wei, Yuchun |
|---|---|
| Zdroj: | Journal of Nuclear Medicine; Nov2024, Vol. 65 Issue 11, p1702-1709, 8p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|